SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0000950135-04-002156
Filing Date
2004-04-29
Accepted
2004-04-29 12:14:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC b50388b2e424b2.htm 424B2 479841
2 GRAPHIC b50388b2b5038801.gif GRAPHIC 1611
  Complete submission text file 0000950135-04-002156.txt   482939
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-51772 | Film No.: 04763470
SIC: 2836 Biological Products, (No Diagnostic Substances)